Company news

Bright Minds Biosciences Inc. news in 2024

Bright Minds Biosciences Inc.'s news releases, calls and decks from 2024, newest first.

Annual Report for Fiscal Year Ending September 30, 2024 (Form 20-F)

December 31, 2024

Bright Minds is Unaware of Any Material Changes

October 15, 2024

Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy

September 12, 2024

Decks in 2024

Investor Presentation (September 2024)
Investor deck · 25 slides · September 2024